Quest Diagnostics Inc (NYSE:DGX)
| 137.75 Delayed Data As of Jan 21 |  +0.58 / +0.42%Today’s Change | 113.36 Today|||52-Week Range 174.16 | -20.38% Year-to-Date |
DGX Regular Dividend: DGX began trading ex-dividend on 01/18/22. A $0.62 dividend will be paid to shareholders of record as of 01/19/22.
Latest DGX News | Press Releases
| Down 17.9% in 4 Weeks, Here's Why Quest Diagnostics (DGX) Looks Ripe for a Turnaround Jan 21 / Zacks.com - Paid Partner Content | Quest Diagnostics (DGX) Posts Preliminary Q4 & 2021 Results Jan 13 / Zacks.com - Paid Partner Content |
| Quest Diagnostics (DGX) Expands Extended Care With New Buyout Jan 19 / Zacks.com - Paid Partner Content | Why Quest Diagnostics Fell Nearly 7% Today Jan 12 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 137.17 |
| Today’s open | 138.22 |
| Day’s range | 136.95 - 139.20 |
| Volume | 1,156,617 |
| Average volume (3 months) | 1,276,919 |
| Market cap | $16.8B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -7.06% |
| Revenue growth (last year) | +14.34% |
| P/E ratio | 8.3 |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LHLaboratory Corporati... | +0.57 | +0.21% |
| GHGuardant Health Inc | -2.57 | -3.53% |
| NTRANatera Inc | -0.28 | -0.44% |
| NEONeogenomics Inc | -0.29 | -1.33% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | February 3, 2022 |
| EPS forecast (this quarter) | $3.18 |
| Annual revenue (last year) | $10.8B |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Secaucus, New Jersey |
Forecasts
